Home Research Policy Clinical Practice For Parents ASI Products & Services Resources About Us  
  TRI Sections red bar

SENIOR TRI INVESTIGATORS AND ADMINISTRATORS

Treatment Research Solutions Group

Ms. Meghan Love, Senior Program Manager, has significant past project experience that includes management of counselor training studies on electronic resource guides linking substance abuse patients to low-cost auxiliary services (NIDA and NIAAA funding), and coordination of a NIDA R21 Exploratory Grant evaluating a concurrent recovery monitoring project in the state of Delaware. From 1998 to 2004 she managed the ONDCP-funded DENS project, a multi-site electronic data collection and reporting system that tracked patterns of drug and alcohol abuse across the nation. Other NIDA-funded studies she managed include, in collaboration with the University of Pennsylvania, a study of patient-treatment matching utilizing the ASI as the primary data collection tool; development of an Employee Assistance Program survey estimating the prevalence of drug and alcohol abuse in school and workplace populations; and development of the Substance Abuse Relapse Reduction System (SARRS) for early detection of individuals at high risk for relapse during the critical first six months of the post-treatment recovery period. The empirically-developed products and services Ms. Love has helped TRI introduce include the Risk and Needs Triage™ helping court officials assign drug-involved offenders to the appropriate disposition; TRI-CEP™, a web-based system to adaptively manage clients and conduct problem-solving court evaluation; and CASPAR-C™, an electronic patient assessment and referral system.

Van Lam, Web Product Developer, provides technical leadership to teams of researchers, administrators and other specialists on science-based product development. He also serves as technical liaison to state and local government purchasers for adaptive, support and training functions. Mr. Lam led technical development of TRI’s Risk and Needs Triage™, TRI-CEP™, and CASPAR-C™, a software application helping treatment counselors create a searchable database of patient services available in their area. He was senior developer for the ONDCP-funded DENS™, an ASI-based patient assessment tool linking client assessment to treatment planning. Other pending projects include an electronic decision support system enabling continuous recovery monitoring at the provider level. Mr. Lam joined TRI in 1996 following other positions in the Philadelphia area at Merck Pharmaceuticals and Corning-Besselaar. He is a 2002 graduate of Drexel University where he earned a Bachelor of Science in Computer Science.

 

Clinical Trials Network

Dr. Woody- George Woody, M.D., Principal Investigator: Dr. Woody is a Professor in the Department of Psychiatry at the University of Pennsylvania. Following a long career in the mental health and substance abuse fields, his research began in 1971 at the Drug Dependence Treatment Unit of the Philadelphia Veterans Affairs Medical Center (VAMC) and the University of Pennsylvania where his overall interest became the efficacy of psychosocial and pharmacological treatments for addiction; the relationship between drugs of abuse, psychiatric symptoms, and treatment outcome; and on risk factors for HIV infection among persons who abuse drugs and how risk can be reduced. He has been an active participant in projects evaluating naltrexone (in the U.S. and in Russia), psychotherapy and counseling for persons with cocaine dependence, and buprenorphine for treatment of heroin addiction. In 1999 he became the principal investigator of the Delaware Valley Node of the National Institute on Drug Abuse Clinical Trials Network (CTN, and in 2003, received a Senior Scientist award from the National Institute of Drug Abuse to allow him to spend less time on clinical work and more on research. Dr. Woody’s numerous accomplishments and affiliations include authoring or co-authoring more than 200 publications and co-editing Treatment Improvement Protocols on methadone maintenance published by the U.S. Substance Abuse and Mental Health Administration. He helped develop Addiction Treatment Practice Guidelines for the Department of Veterans Affairs, is a member of research groups studying the abuse liability of tramadol and prescription opioids, and is a founding member of the Board of Addiction Psychiatry of the American Psychiatric Association.


* Behavioral Treatments and Applications
* Law & Ethics-
* Center on the Continuum of Care:-
Monitoring and Adapting Addiction Treatment
* Center for Policy Research and-
Analysis

* Parents Translational Research Center
* Adolescents-
* Treatment Research Solutions-
* Clinical Trials Network-

-
  Quick Links


* Projects-at-a-Glance

* TRI Collaborators
* Addiction Severity Index (ASI)-
* Other Assessment Instruments-
* Publications-
* Presentations-
* Archives-
* Training-
* Order TRI Resources-
* Career Opportunities -
* Contact Us-

* Research Briefs
* Sign up for E-Alerts-